Search by Drug Name or NDC
NDC 61919-0607-03 LORAZEPAM 1 mg/1 Details
LORAZEPAM 1 mg/1
LORAZEPAM is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DirectRX. The primary component is LORAZEPAM.
MedlinePlus Drug Summary
Lorazepam is used to relieve anxiety. Lorazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow for relaxation.
Related Packages: 61919-0607-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lorazepam
Product Information
| NDC | 61919-0607 |
|---|---|
| Product ID | 61919-607_fed03a1c-0eac-1f8e-e053-6394a90a04c0 |
| Associated GPIs | 57100060000310 |
| GCN Sequence Number | 003758 |
| GCN Sequence Number Description | lorazepam TABLET 1 MG ORAL |
| HIC3 | H20 |
| HIC3 Description | ANTI-ANXIETY - BENZODIAZEPINES |
| GCN | 14161 |
| HICL Sequence Number | 004846 |
| HICL Sequence Number Description | LORAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | LORAZEPAM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LORAZEPAM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | mg/1 |
| Substance Name | LORAZEPAM |
| Labeler Name | DirectRX |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA078203 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0607-03 (61919060703)
| NDC Package Code | 61919-607-03 |
|---|---|
| Billing NDC | 61919060703 |
| Package | 3 TABLET in 1 BOTTLE (61919-607-03) |
| Marketing Start Date | 2019-04-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |